A Prospective Single Center Pilot to Study Using the The CathVision ECGenius System to Collect Electrogram Data to Test an Ablation Impact Algorithm

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Persistent Atrial Fibrillation
  • Age: Between 21 - 100 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Patients scheduled for Radiofrequency (RF) ablation indicated by the investigator for the treatment of persistent atrial fibrillation
    2. Able and willing to provide written informed consent prior to any clinical investigation related procedure

You may not be eligible for this study if the following are true:

    1. Current participation in another investigational drug or device study that interferes with this study
    2. Patients who, in the opinion of the investigator, are not candidates for this study
    3. Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the patient's ability to participate in the clinical investigation or to comply with follow-up requirements, or impact the scientific soundness of the clinical investigation results
    4. Life expectancy less than 12 month, in the opinion of the Investigator
    5. Patients who are considered part of any vulnerable population
    6. Patient is a prisoner



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.